LEADER 01217nam  2200385   450 
001 000001765
005 20070503173300.0
100   $a--------d1961----km-y0itay0103----ba
101 0 $aeng
102   $aUS
200 1 $a<<The>> astonished muse$fS. L. M. Barlow
200 1 $a1 $n0003395
210   $aNew York$cDay$dc1961
215   $a320 p.$d21 cm.
676   $a810
700  1$aBarlow,$bSamuel L. M.$0438764
801  0$aIT$bUniversitą della Basilicata - B.I.A.$gRICA$2unimarc
912   $a000001765
996   $aAstonished muse$972001
997   $aUNIBAS
BAS   $aMONLET
BAS   $aMONOGR
BAS   $aLETTERE
CAT   $aNANNI$b01$c19990729$lBAS01$h1326
CAT   $aDILEO$b20$c19990810$lBAS01$h1517
CAT   $c20000920$lBAS01$h1829
CAT   $c20001010$lBAS01$h1632
CAT   $c20050601$lBAS01$h1752
CAT   $abatch$b01$c20050718$lBAS01$h1047
CAT   $c20050718$lBAS01$h1106
CAT   $c20050718$lBAS01$h1136
CAT   $c20050718$lBAS01$h1150
CAT   $aBATCH$b00$c20070503$lBAS01$h1733
FMT   
Z30 -1$lBAS01$LBAS01$mBOOK$1BASA1$APolo Storico-Umanistico$2GEN$BCollezione generale$3FP/2338$9FP/2338$62338$5L2338$819990729$f02$FPrestabile Generale

LEADER 01857nam  2200445   450 
001 9910693869903321
005 20221024193048.0
035   $a(CKB)3450000000002494
035   $a(NjHacI)993450000000002494
035   $a(OCoLC)55017158
035 9 $aocm55017158
035   $a(OCoLC)993450000000002494
035   $a(EXLCZ)993450000000002494
100   $a20221024d2004      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aEffects of omega-3 fatty acids on lipids and glycemic control in type II diabetes and the metabolic syndrome and on inflammatory bowel disease, rheumatoid arthritis, renal disease, systemic lupus erythematosus, and osteoporosis /$fCatherine H. MacLean [and eleven others]
210  1$aRockville (MD) :$cAgency for Healthcare Research and Quality (US),$d[2004]
210  4$d©2004
215   $a1 online resource (4 pages) $cillustrations
225 1 $aEvidence report/technology assessment. Summary ;$vno. 89
225 1 $aAHRQ pub. ;$vno. 04-E012-1
300   $aTitle from title screen (viewed on Apr. 24, 2004).
320   $aIncludes bibliographical references.
606   $aOmega-3 fatty acids
606   $aMeta-analysis
615  0$aOmega-3 fatty acids.
615  0$aMeta-analysis.
676   $a612.397
700   $aMacLean$b Catherine H.$01351585
712 02$aUnited States.$bAgency for Healthcare Research and Quality.
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910693869903321
996   $aEffects of omega-3 fatty acids on lipids and glycemic control in type II diabetes and the metabolic syndrome and on inflammatory bowel disease, rheumatoid arthritis, renal disease, systemic lupus erythematosus, and osteoporosis$93121139
997   $aUNINA